代谢危险因素对慢性乙型肝炎男性肝细胞癌及肝病相关死亡风险的影响:一项大型队列研究
研究纳入1989至1992年台湾5373名男性公务员体检数据,分析1690名40-65岁HBV携带者代谢危险因素与HCC及肝病死亡风险。中位随访19年,携带者中158例发生HCC、126例死于肝病;≥3个代谢危险因素者10年HCC累积发病率13.60%,低于风险组为4.83%(调整HR 2.32,95%CI 1.18-4.54)。吸烟显著影响该关联(交互P=.0044)。
要点
- HBV携带者中≥3个代谢危险因素者10年HCC累积发病率为13.60%,低代谢风险组为4.83%。
- 吸烟者中≥3个代谢危险因素较无因素者HCC风险调整HR为5.06(95%CI 2.23-11.47)。
- 代谢危险因素和胰岛素抵抗对HBV-DNA<10,000 copies/mL者HCC风险影响最大。
核心结论
- 在台湾40-65岁慢性HBV感染男性中,高代谢危险因素负担与HCC风险升高相关;吸烟对该关联有显著影响。
研究设计与样本
- 研究收集1989至1992年台湾5373名男性公务员在政府员工中央诊所免费体检的数据。
- 纳入40-65岁HBV携带者1690例,并与同年龄段无HBV或HCV感染者1289例比较病史。
- 根据基线肥胖、糖尿病、高甘油三酯血症和高血压将患者分为代谢风险类别。
- 基于代谢因素和胰岛素抵抗进行病例队列分析,评估HBV病毒因素对HCC风险的影响。
主要发现
- 中位随访19年,1690例HBV携带者中158例发生HCC,126例死于肝病;无HBV或HCV感染者中仅6例发生HCC或死于肝病。
- ≥3个代谢危险因素者10年HCC累积发病率为13.60%,低代谢风险者为4.83%,调整HR为2.32(95%CI 1.18-4.54)。
- 吸烟对该关联有显著影响(交互作用P=.0044)。
- 吸烟者中≥3个代谢危险因素较无因素者HCC调整HR为5.06(95%CI 2.23-11.47),10年累积发病率25.0% vs 3.87%(P<.0001);非吸烟者中未增加HCC风险。
- 在HBV-DNA<10,000 copies/mL的患者中,代谢危险因素和胰岛素抵抗对HCC风险影响最大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little is known about the absolute risk of hepatocellular carcinoma (HCC) and liver-disease related death, in association with metabolic risk factors, for patients with hepatitis B virus (HBV) infection. METHODS: We collected data from 5373 male Taiwanese civil servants who visited Taiwan's Government Employees' Central Clinics and received routine free physical examinations from 1989 through 1992. We obtained information on liver-related morbidity and mortality in HBV carriers, 40-65 years of age (n=1690), with different metabolic risk factors. We compared their medical histories with those of study participants without HBV or HCV infection in the same age range (n=1289). We used patients' baseline data on obesity, diabetes, hypertriglyceridemia, and high blood pressure to assign them to metabolic risk categories. We then performed a case-cohort analysis of the effects of hepatitis B viral factors on risk for HCC, based on metabolic factors and insulin resistance. RESULTS: Over a median follow-up period of 19 years, 158 of the 1690 HBV carriers developed HCC and 126 died from liver-related diseases. Among participants without HBV or HCV infection, only 6 developed HCC or died from liver-related disease. HBV carriers with different metabolic risk factors had significant differences in cumulative incidence of HCC and liver-related death. Patients with 3 or more metabolic risk factors had a substantially higher risk for HCC (10-year cumulative incidence, 13.60%) than patients with a low metabolic risk profile (10-year cumulative incidence, 4.83%; adjusted-hazard ratio, 2.32; 95% CI, 1.18-4.54). Smoking had a significant effect on this association (Pinteraction = .0044). Having 3 or more metabolic risk factors, compared with no factors, significantly increased the risk of HCC (adjusted-hazard ratio, 5.06; 95% CI, 2.23-11.47) and 10-year cumulative incidence of HCC (25.0% in smokers with 3 or more metabolic risk factors vs 3.87% in smokers with none; P < .0001) in smokers, but did not increase risk of HCC in nonsmokers. Metabolic risk factors and insulin resistance had the largest effect on HCC risk in patients with levels of HBV-DNA <10,000 copies/mL. CONCLUSIONS: In a study of men with chronic HBV infection ages 40-65 years in Taiwan, we associated a high burden of metabolic risk factors with increased risk of HCC; smoking has a significant effect on this association.
引用
- Yu MW, Lin CL, Liu CJ, et al. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study. Gastroenterology. 2017. PMID: 28711626. doi:10.1053/j.gastro.2017.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。